Martin Cross

Martin Cross

Director/Miembro de la Junta en Nhmrc National Institute of Dementia Research .

Fortuna: 14 661 $ al 30/04/2024

Health Technology
Consumer Non-Durables
Consumer Services

Perfil

Martin Cross currently works at Nhmrc National Institute of Dementia Research, as Non-Executive Director.
Dr. Cross also formerly worked at Generic Medicines Industry Association Pty Ltd., as Chairman from 2010 to 2013, Medicines Australia, as Chairman from 2013 to 2015, Anagenics Ltd., as Non-Executive Director from 2017 to 2023, OncoSil Medical Ltd., as Independent Non-Executive Director from 2017 to 2022, Alphapharm Pty Ltd., as Managing Director from 2010 to 2013, Novartis Australia Pty Ltd., as Managing Director & Head-Country from 2003 to 2008, Novartis New Zealand Ltd., as Managing Director & Head-Country from 2003 to 2008, and Novartis AG, as Head-Global Marketing from 2001 to 2003.
Dr. Cross received his undergraduate degree and doctorate degree from the University of Aberdeen.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/10/2022 4 510 965 ( 0.15% ) 14 661 $ 30/04/2024

Cargos activos de Martin Cross

EmpresasCargoInicio
Nhmrc National Institute of Dementia Research Director/Miembro de la Junta -
Todos los cargos activos de Martin Cross

Antiguos cargos conocidos de Martin Cross.

EmpresasCargoFin
ANAGENICS LIMITED Director/Miembro de la Junta 27/11/2023
ONCOSIL MEDICAL LIMITED Director/Miembro de la Junta 24/10/2022
Presidente 01/01/2015
Director Ejecutivo 01/10/2013
Presidente 01/01/2013
Ver el detalle de la experiencia de Martin Cross.

Formación de Martin Cross.

University of Aberdeen Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Martin Cross.

Relaciones

69

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
ANAGENICS LIMITED

Consumer Non-Durables

NOVARTIS AG

Health Technology

ONCOSIL MEDICAL LIMITED

Health Technology

Empresas privadas6

Health Technology

Commercial Services

Health Technology

Distribution Services

Health Technology

Nhmrc National Institute of Dementia Research

Ver las conexiones de la empresa